Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Just Think About It: Neuro-Prostheses Are Not Far Off, Ossur Says

This article was originally published in The Gray Sheet

Executive Summary

Ossur expects to reach clinical trials with early applications of its neurosensing technology within the next two years, enabling prosthetic limb users to exercise voluntary control over the device at a neurological level, according to VP-Research & Development Hilmar Janusson

You may also be interested in...



Devices Rank Front And Center In Cleveland Clinic’s 'Top 10' Picks

The Cleveland Clinic has identified seven up-and-coming device technologies that are likely to have major clinical impact and see near-term commercial success, as part of its annual “Top 10 Medical Innovations” list.

Devices Rank Front And Center In Cleveland Clinic’s 'Top 10' Picks

The Cleveland Clinic has identified seven up-and-coming device technologies that are likely to have major clinical impact and see near-term commercial success, as part of its annual “Top 10 Medical Innovations” list.

CIBC World Markets Healthcare Conference In Brief

Integra finds Newdeal for foot repair: Acquisition of French reconstructive surgery device maker Newdeal for $50 mil. Nov. 14 adds specialty implants and instruments for foot and angle surgery. Key offerings include Bold screws, Hallu-Fix plates and Hintegra total ankle prostheses sold through direct reps in France, Belgium and the Netherlands, as well as distributors in the U.S. and other countries. Newdeal sales totaled about $18 mil. in 2003. Integra expects the devices to dovetail with its own regenerative offerings, including Integra dermal regeneration templates and wound dressings, and NeuraGen and NeuraWrap nerve repair products - which can be used to treat foot and ankle wounds. During a Nov. 9 session of the CIBC meeting in New York, Integra CEO Stuart Essig noted that the firm's peripheral nerve injury offerings were "growing quickly," aided by the September launch of the 510(k)-cleared NeuraWrap collagen nerve repair conduit for injured, compressed or scarred nerves. The line includes NeuraGen, launched in 2001 for completely severed nerves...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel